Obtaining optimal control in mild asthma: theory and practice

Area of Science:

• General Practice Research
• Respiratory Medicine
• Pharmacovigilance

Background:

• Asthma severity is frequently underestimated, leading to undertreatment and reduced disease control.
• Suboptimal asthma management impacts a significant patient population.

Purpose of the Study:

• To investigate asthma control in patients treated with short-acting beta-agonist (SABA) alone versus those receiving inhaled corticosteroids (ICS) in addition to SABA.
• To identify factors associated with asthma control and medication prescribing patterns in general practice.

Main Methods:

• Retrospective analysis of patients (0-45 years) diagnosed with asthma between 1995-2001 from the General Practice Research Database (GPRD).
• Patients were categorized into SABA-only or ICS groups based on initial medication prescriptions within six months of diagnosis.
• Assessment of drug prescription rates and factors influencing treatment escalation and oral steroid use.

Main Results:

• High SABA prescription rates (>1 dose/day) were observed in both SABA-only and ICS groups.
• A notable percentage of patients in both groups used oral steroids.
• Within the SABA-only group, 37% were escalated to ICS, with prior hospitalization and atopy significantly associated with this step-up.
• Female sex, atopy, smoking, and prior hospitalization were linked to increased oral steroid use and poorer asthma control.

Conclusions:

• Asthma control is suboptimal in a substantial proportion of patients, even with initial SABA or SABA/ICS treatment in general practice.
• Identifying atopic, female, smoking patients, and those with prior hospitalizations can help physicians predict and manage poor asthma control.
• These patient characteristics can guide proactive treatment adjustments to improve asthma outcomes.